feed,title,long_url,short_url
FortuneBusinessInsights,Nuclear Medicine Market to Record 19.5% CAGR from 2023 to 2030; GE Healthcare Expands Portfolio with Acquisition of Zionexa and FDA Approval of Cerianna for Metastatic Breast Cancer,https://www.fortunebusinessinsights.com/press-release/nuclear-medicine-radiopharmaceuticals-market-9463,https://da.gd/nQIH
